Our analysis identified differentially methylated sites in tumor or immune cell expressed genes, particularly ITGB7 and suggest that NRAS mutated MBM might feature a more progressive phenotype as observed before in primary melanoma96. The gene discussed is NRAS; the disease is neoplasm.